Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,017 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Case Report: Should Regorafenib be prescribed as a continuous schedule in gastrointestinal stromal tumors? Three case reports on Regorafenib personalized schedule.
Grimaudo MS, Laffi A, Gennaro N, Fazio R, D'Orazio F, Samà L, Siracusano LV, Sicoli F, Renne SL, Santoro A, Bertuzzi AF. Grimaudo MS, et al. Among authors: santoro a. Front Oncol. 2023 May 31;13:1190123. doi: 10.3389/fonc.2023.1190123. eCollection 2023. Front Oncol. 2023. PMID: 37324004 Free PMC article.
Ribociclib-Induced Cutaneous Adverse Events in Metastatic HR+/HER2- Breast Cancer: Incidence, Multidisciplinary Management, and Prognostic Implication.
Borroni RG, Bartolini M, Gaudio M, Jacobs F, Benvenuti C, Gerosa R, Tiberio P, Manara SAAM, Solferino A, Santoro A, De Sanctis R. Borroni RG, et al. Among authors: santoro a. Oncologist. 2024 Jan 18:oyae004. doi: 10.1093/oncolo/oyae004. Online ahead of print. Oncologist. 2024. PMID: 38242689 Free article.
Lynch Syndrome: From Multidisciplinary Management to Precision Prevention.
Dal Buono A, Puccini A, Franchellucci G, Airoldi M, Bartolini M, Bianchi P, Santoro A, Repici A, Hassan C. Dal Buono A, et al. Among authors: santoro a. Cancers (Basel). 2024 Feb 20;16(5):849. doi: 10.3390/cancers16050849. Cancers (Basel). 2024. PMID: 38473212 Free PMC article. Review.
Autoimmunity in thymic epithelial tumors: a not yet clarified pathologic paradigm associated with several unmet clinical needs.
Perrino M, Voulaz E, Balin S, Cazzato G, Fontana E, Franzese S, Defendi M, De Vincenzo F, Cordua N, Tamma R, Borea F, Aliprandi M, Airoldi M, Cecchi LG, Fazio R, Alloisio M, Marulli G, Santoro A, Di Tommaso L, Ingravallo G, Russo L, Da Rin G, Villa A, Della Bella S, Zucali PA, Mavilio D. Perrino M, et al. Among authors: santoro a. Front Immunol. 2024 Apr 2;15:1288045. doi: 10.3389/fimmu.2024.1288045. eCollection 2024. Front Immunol. 2024. PMID: 38629065 Free PMC article. Review.
HR+/HER2- de novo metastatic breast cancer: a true peculiar entity?
Torrisi R, Jacobs F, Miggiano C, De Sanctis R, Santoro A. Torrisi R, et al. Among authors: santoro a. Drugs Context. 2023 Mar 6;12:2022-12-2. doi: 10.7573/dic.2022-12-2. eCollection 2023. Drugs Context. 2023. PMID: 36926051 Free PMC article. Review.
Target Therapy in Malignant Pleural Mesothelioma: Hope or Mirage?
Borea F, Franczak MA, Garcia M, Perrino M, Cordua N, Smolenski RT, Peters GJ, Dziadziuszko R, Santoro A, Zucali PA, Giovannetti E. Borea F, et al. Among authors: santoro a. Int J Mol Sci. 2023 May 23;24(11):9165. doi: 10.3390/ijms24119165. Int J Mol Sci. 2023. PMID: 37298116 Free PMC article. Review.
Real-world clinical outcomes of patients with stage I HER2-positive breast cancer treated with adjuvant paclitaxel and trastuzumab.
Debien V, Marta GN, Agostinetto E, Sirico M, Jacobs F, Molinelli C, Moreau M, Paesmans M, De Giorgi U, Santoro A, Taylor D, Duhoux FP, Botticelli A, Barchiesi G, Speranza I, Lambertini M, Wildiers H, Azambuja E, Piccart M. Debien V, et al. Among authors: santoro a. Crit Rev Oncol Hematol. 2023 Oct;190:104089. doi: 10.1016/j.critrevonc.2023.104089. Epub 2023 Aug 9. Crit Rev Oncol Hematol. 2023. PMID: 37562696 Review.
3,017 results